Abstract:<p>Rapid detection of severe fever with thrombocytopenia syndrome virus (SFTSV) is crucial for its control and surveillance. In this study, a rapid isothermal real-time reverse-transcription recombinase polymerase amplification (RT-RPA) assay was developed for the detection of SFTSV. The detection limit at 95% probability was 241 copies per reaction. A test of 120 serum samples of suspected severe fever with thrombocytopenia syndrome (SFTS) patients revealed that the sensitivity and specificity of the RT-RPA assay was approximately 96.00% (95%CI: 80.46%–99.79%) and 98.95% (95% CI: 94.28%–99.95%), respectively; the kappa value was 0.9495 (P<0.001). The Bland-Altman analysis showed that 87.50% of the different data points were located within the 95% limits of agreement, indicating a good correlation between the results from RT-RPA assays and those of RT-qPCR assays. In conclusion, the rapid and efficient RT-RPA assay can be a promising candidate for point-of-care detection method of SFTSV.</p>

What problem does this paper attempt to address?

This paper aims to develop a method for rapid detection of Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV), in order to improve the early diagnosis ability of this virus infection and prevent virus transmission. Specifically, the researchers developed a rapid detection method based on reverse transcription - recombinase polymerase amplification (RT - RPA) technology for the detection of SFTSV nucleic acids in clinical samples. The paper describes in detail the establishment process, optimization conditions of this method and the evaluation of its application effect in clinical samples, especially the analysis of its sensitivity, specificity and consistency with the traditional RT - qPCR method. ### Main problems: 1. **Early diagnosis and control**: Since the clinical manifestations of SFTSV infection are not specific and the disease progresses rapidly, which may lead to multi - organ dysfunction, early diagnosis is crucial for improving patient prognosis and controlling the spread of the epidemic. 2. **Limitations of existing detection methods**: Currently, the commonly used SFTSV detection methods include serological detection, virus isolation and PCR - based nucleic acid detection. However, these methods have some limitations. For example, serological detection and virus isolation are time - consuming, and the PCR method requires complex equipment and professional personnel to operate, and is not suitable for areas with limited resources. ### Solutions: 1. **RT - RPA technology**: The researchers developed a rapid detection method based on RT - RPA technology. This method has the following advantages: - **Rapid**: The detection time is less than 30 minutes, while the traditional RT - qPCR method usually takes more than 1.5 hours. - **Simple**: The reaction temperature is constant (39°C) and can be carried out in a simple water bath or metal bath without the need for a complex thermal cycler. - **High sensitivity and specificity**: The limit of detection is 241 target RNA copies per reaction, with a sensitivity of approximately 96.00% and a specificity of approximately 98.95%. 2. **Clinical verification**: By detecting 120 serum samples from suspected SFTS patients, the results showed a high consistency between the RT - RPA method and the RT - qPCR method, with a Kappa value of 0.9495 (P < 0.001), and Bland - Altman analysis also indicated a good correlation between the results of the two methods. ### Conclusion: As a rapid, efficient and simple detection method, RT - RPA technology is particularly suitable as an on - site detection means for SFTSV in areas with limited resources, which is helpful for early diagnosis and epidemic control.

Development and evaluation of a rapid detection assay for severe fever with thrombocytopenia syndrome virus based on reverse-transcription recombinase polymerase amplification

Establishment of a Novel One-Step Reverse Transcription Loop-Mediated Isothermal Amplification Assay for Rapid Identification of RNA from the Severe Fever with Thrombocytopenia Syndrome Virus.

Development and characterization of a digital CRISPR/Cas13a based assay for rapid and sensitive diagnosis of severe fever with thrombocytopenia syndrome virus

CRISPR/Cas12a Technology Combined With RPA for Rapid and Portable SFTSV Detection

Rapid Detection of Influenza A Viruses Using a Real-Time Reverse Transcription Recombinase-Aided Amplification Assay.

Rapid and portable bunyavirus SFTSV RNA testing utilizing catalytic hairpin assembly coupled with lateral flow immunoassay

Enhancing Sensitivity in Detecting Severe Fever With Thrombocytopenia Syndrome Virus: Development of a Reverse Transcription–Droplet Digital Polymerase Chain Reaction

Ultra-rapid detection of nuclear protein of severe fever with thrombocytopenia syndrome virus by colloidal gold immunochromatography assay

Dual-gene detection in a single-tube system based on CRISPR-Cas12a/Cas13a for severe fever thrombocytopenia syndrome virus

Ultrasensitive Detection of Severe Fever with Thrombocytopenia Syndrome Virus Based on Immunofluorescent Carbon Dots/SiO2 Nanosphere-Based Lateral Flow Assay

Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B

A new luciferase immunoprecipitation system assay provided serological evidence for missed diagnosis of severe fever with thrombocytopenia syndrome

Rapid and Accurate Detection of Three Genes in SARS-CoV-2 Using RT-LAMP Method

Development of an all-in-one real-time PCR assay for simultaneous detection of spotted fever group rickettsiae, severe fever with thrombocytopenia syndrome virus and orthohantavirus hantanense prevalent in central China

Development of an all-in-one real-time PCR assay for simultaneous detection of spotted fever group rickettsiae, severe fever with thrombocytopenia syndrome virus and hantaan virus prevalent in central China

Development of a reverse transcription recombinase polymerase amplification assay for rapid detection of human respiratory syncytial virus

Rapid and Sensitive Identification of RNA from the Emerging Pathogen, Coxsackievirus A6

Development and evaluation of a real-time RT-PCR and a field-deployable RT-insulated isothermal PCR for the detection of Seneca Valley virus

Development and evaluation of time-resolved fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike antigen

Development of a reverse transcription recombinase polymerase amplification assay for rapid and direct visual detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Clinical Validation of Two Recombinase-Based Isothermal Amplification Assays (RPA/RAA) for the Rapid Detection of African Swine Fever Virus